Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
Gilead researchers say lenacapavir “has the potential to be one of the most impactful interventions” in the battle against HIV.
October 15 2024 5:03 PM
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Gilead researchers say lenacapavir “has the potential to be one of the most impactful interventions” in the battle against HIV.
Students in Philadelphia proved anybody has what it takes to be a scientist,
Kundai Chinyenze leads a global initiative that refuses to stop until a vaccine is found.
A new study shows hope for the 10 percent of HIV-positive patients who cannot rely on initial treatment meds.
Recent research shows the popular HIV treatment drug is a safe and highly effective treatment option for those also living with hepatitis B.
Here’s the latest on a genetic editing technique with the potential to permanently eliminate HIV from the body.
Though the “highly virulent” strain was just identified, it’s actually been around since the ’90s and is easily controlled by HIV treatment.
Doxycycline may be the next frontier for queer men and trans women at high risk for certain STIs.
A new study delves into how stem cell transplantation can kill the virus behind AIDS.
Smoking is particularly dangerous for people living with HIV.
Paul Edmonds, the fifth person to be cured via a stem cell transplant, recently opened up about his experience.
The first Phase 3 trial for a potential HIV vaccine has ended in disappointment.
Gilead Sciences has backed George Washington University for the 18-month initiative.
The drug company revealed promising long-term data at the 2022 Glasgow HIV conference, including news on cure development.
When searching for the cure for HIV, it’s imperative to include disproportionately affected communities in drug trials to ensure a vaccine for everybody.
The drug clears toxic brain proteins and had positive results in mice.
The vaccine uses an engineered protein from within the virus.
Canadian researchers look at how non-neutralizing antibodies affect the virus.
A government grant will fund an HIV-focused biomedical research space at Whitman-Walker Health.
A woman is in HIV “remission” due to a rare and risky procedure but the White House's Dr. Anthony Fauci warns this method can't be “applied to the 36 million who are living with HIV.”